Last reviewed · How we verify

NCT06178822: BIOSEP

Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room

Recruiting now Last updated 2 October 2025
What this trial tests

trial testing No intervention in Sepsis in 3,300 participants. Currently enrolling.

Timeline
25 October 2022
Primary endpoint
1 October 2026
1 October 2026

Quick facts

Lead sponsorAmsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment3,300
Start date25 October 2022
Primary completion1 October 2026
Estimated completion1 October 2026
Sites3 locations across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)

Who can join

18 and older, any sex, with Sepsis or Septic Shock. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objectives: 1. To compare the immune response of patients with or without sepsis presenting to the ED with a(n) (suspected) infection. 2. To determine immune response aberrations that are associated with an increased risk of developing sepsis in patients presenting to the ED with a(n) (suspected) infection without sepsis. 3. To determine the long term cognitive and physical sequelae of sepsis after admission.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Biomarkers to guide sepsis management.
    Bourika V, Rekoumi EA, Giamarellos-Bourboulis EJ. · · 2025 · cited 5× · PMID 40685448 · DOI 10.1186/s13613-025-01524-1
  2. Towards novel BIOmarkers to diagnose SEPsis (BIOSEP) in the emergency room: a protocol for a multicentre, prospective cohort study.
    Reijnders E, Turgman O, Joosten SCM, Schinkel M, et al · · 2025 · PMID 40750284 · DOI 10.1136/bmjopen-2025-103138

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Sepsis

Currently open trials in the same condition.

Other Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06178822.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing